日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

用于治疗实体瘤患者的白细胞介素-15修饰的GPC3 CAR T细胞

David Steffin ,Nisha Ghatwai ,Antonino Montalbano ,Purva Rathi ,Amy N Courtney ,Azlann B Arnett ,Julien Fleurence ,Ramy Sweidan ,Tao Wang ,Huimin Zhang ,Prakash Masand ,John M Maris ,Daniel Martinez ,Jennifer Pogoriler ,Navin Varadarajan ,Sachin G Thakkar ,Deborah Lyon ,Natalia Lapteva ,Mei Zhuyong ,Kalyani Patel ,Dolores Lopez-Terrada ,Carlos A Ramos ,Premal Lulla ,Tannaz Armaghany ,Bambi J Grilley ,Stephen Gottschalk ,Gianpietro Dotti ,Leonid S Metelitsa ,Helen E Heslop ,Malcolm K Brenner ,Pavel Sumazin ,Andras Heczey

Coordinated regulation by lncRNAs results in tight lncRNA-target couplings

lncRNA的协同调控导致lncRNA与靶标之间紧密结合。

Hua-Sheng Chiu,Sonal Somvanshi,Chung-Te Chang,Eric James de Bony de Lavergne,Zhaowen Wei,Chih-Hung Hsieh,Wim Trypsteen,Kathleen A Scorsone,Ektaben Patel,Tien T Tang,David B Flint,Mohammad Javad Najaf Panah,Hyunjae Ryan Kim,Purva Rathi,Yan-Hwa Wu Lee,Sarah E Woodfield,Sanjeev A Vasudevan,Andras Attila Heczey,M Waleed Gaber,Gabriel O Sawakuchi,Ting-Wen Chen,Pieter Mestdagh,Xuerui Yang,Pavel Sumazin

Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15

神经母细胞瘤患者接受表达GD2特异性嵌合抗原受体和IL-15的自然杀伤T细胞治疗后出现白细胞增多症

Tian, Gengwen; Courtney, Amy N; Yu, Hangjin; Bhar, Saleh; Xu, Xin; Barragán, Gabriel A; Martinez Amador, Claudia; Ghatwai, Nisha; Wood, Michael S; Schady, Deborah; Montalbano, Antonino; Reddy, Shantan; Roche, Aoife M; de la Cerda, David; Parsons, Donald Williams; Di Pierro, Erica J; Bushman, Frederic D; Heczey, Andras; Metelitsa, Leonid S

Response to: Correspondence on "Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15" by Ataca Atilla and Atilla

回复:Ataca Atilla 和 Atilla 的来信“用表达 GD2 特异性嵌合抗原受体和 IL-15 的自然杀伤 T 细胞治疗神经母细胞瘤患者后出现白细胞增多症”。

Tian, Gengwen; Courtney, Amy N; Heczey, Andras; Metelitsa, Leonid S

MRI-Based Radiomics for Outcome Stratification in Pediatric Osteosarcoma

基于磁共振成像的放射组学在儿童骨肉瘤预后分层中的应用

Ngan, Esther; Mullikin, Dolores; Theruvath, Ashok J; Annapragada, Ananth V; Ghaghada, Ketan B; Heczey, Andras A; Starosolski, Zbigniew A

Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity

利用ADA1和CD26对CAR T细胞进行选择性补充可增强抗肿瘤免疫力

Yue Hu ,Abhijit Sarkar ,Kevin Song ,Sara Michael ,Magnus Hook ,Ruoning Wang ,Andras Heczey ,Xiaotong Song

Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors

白血病、淋巴瘤和实体瘤患者接受免疫效应细胞治疗和淋巴细胞清除后出现长期血细胞减少症

Miller, Anne; Daum, Rachel; Wang, Tao; Wu, Mengfen; Tat, Candise; Pfeiffer, Thomas; Navai, Shoba; Heczey, Andras; Hegde, Meenakshi; Ahmed, Nabil; Whittle, Sarah B; Hill, LaQuisa; Martinez, Caridad; Krance, Robert; Ramos, Carlos A; Rouce, Rayne H; Lulla, Premal; Heslop, Helen E; Omer, Bilal; Shekar, Meghan

The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience

先天性心脏病对肝母细胞瘤患者治疗和生存的影响:单中心经验

Espinoza, Andres F; Montgomery, Ashley E; Maamari, Nicholas C; Dickerson, Heather A; Heczey, Andras; Vasudevan, Sanjeev A; Foster, Jennifer H

A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019

对2001年至2019年神经母细胞瘤的发病率、生存率以及种族和民族差异进行全面分析

Campbell, Kevin; Siegel, David A; Umaretiya, Puja J; Dai, Shifan; Heczey, Andras; Lupo, Philip J; Schraw, Jeremy M; Thompson, Trevor D; Scheurer, Michael E; Foster, Jennifer H

Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020

美国2001-2020年儿童和成人肝细胞癌的发病率和生存率

Arnett, Azlann; Siegel, David A; Dai, Shifan; Thompson, Trevor D; Foster, Jennifer; di Pierro, Erika J; Momin, Behnoosh; Lupo, Philip J; Heczey, Andras